Related Experiment Videos
Patients' problems with new medication for chronic conditions
N Barber1, J Parsons, S Clifford
1Department of Practice and Policy, The School of Pharmacy, 29/39 Brunswick Square, London WC1N 1AX. nick.barber@ulsop.ac.uk
Quality & Safety in Health Care
|June 4, 2004
Summary
Many patients struggle with new chronic medications, showing poor adherence and experiencing problems. Increased support and services are needed for individuals starting long-term prescriptions.
Area of Science:
- Pharmacology and Patient Adherence
- Chronic Disease Management
- Health Services Research
Background:
- Starting new medication for chronic conditions presents challenges for patients.
- Understanding patient adherence, medication issues, and information needs is crucial for effective chronic disease management.
Purpose of the Study:
- To assess patient adherence to new chronic medications.
- To identify reasons for non-adherence, including intentional vs. unintentional factors.
- To evaluate patient-reported problems and information needs regarding their new medication.
Main Methods:
- A longitudinal survey involving 258 patients from 23 community pharmacies in South East England.
- Data collected via semi-structured telephone interviews and postal questionnaires at 10 days and 4 weeks.
- Inclusion criteria: patients starting new chronic medication, aged 75+, or with specific chronic conditions (stroke, CHD, asthma, diabetes, rheumatoid arthritis).
Main Results:
- Non-adherence was observed in 30% at 10 days and 25% at 4 weeks.
- Approximately half of non-adherence was intentional at both time points.
- 66% reported medication problems at 10 days, and 51-61% expressed ongoing information needs at 4 weeks.
Conclusions:
- A significant number of patients become non-adherent to new chronic medications shortly after initiation, with intentional non-adherence being common.
- Patients frequently encounter problems and have substantial information needs, highlighting a gap in current support.
- Enhanced patient support and potentially new service models are necessary for individuals starting chronic medications.